Health Legislation

This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.

This law, published in the Official Journal on 8 June 2023, establishes the National Health Insurance Fund ("Caisse d'assurance maladie universelle").

This Decree contains provisions for the organization and operation of a public establishment called the Health Solidarity Fund in the Democratic Republic of the Congo.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

The Act regulates the promotion, regulation and integration of health insurance schemes in Nigeria.

This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)

The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.

This decree establishes the terms of organization and operation of the National Health Insurance Fund of Chad.

This Act establishes a National Health Insurance Authority to implement a national health insurance scheme, establishes a national health insurance Fund to pay for the cost of health care services to members of the Scheme, and provides for the establishment of private health insurance schemes.

The Regulation sets up rules in the registration of drugs and related products manufactured, imported, exported, advertised, sold, distributed or used in Nigeria.  

This law establishes a national health insurance Fund ("Caisse Nationale d'Assurance Santé").

Specifications for essential medicines supplies.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

These Regulations provide rules on the registration and access to the market to medicine; licensing requirements for pharmaceutical operations, manufacturers, wholesalers and dispensaries; as well as on record-keeping, import of medicines, and clinical trials, etc.

This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.

The Decree creates a management body called "Caisse nationale d'assurance maladie universelle". It is placed under the technical supervision of the Ministry in charge of social protection and the financial supervision of the Ministry in charge of finance.

This Act provides for sound financing for the national health system; provides for universal access to quality insured health care services; establishes the National Health Insurance Management Authority and provides for its functions and powers; establishes the National Health Insurance Scheme and provides for its systems, procedures and operation; establishes the National Health Insurance Fund and provides for contributions to and payments from the Fund; provides for accreditation criteria and conditions in respect of insured health care services; provides for complaints and appeals processes; provides for the progressive establishment of provincial and district health offices of the Authority; and provides for matters connected with, or incidental to the foregoing.

The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).

This Law establishes the rules for the efficient and safe production, distribution, use and availability, as well as quality assurance of medicines, vaccines, biological and health products for citizens.

This Act repeals and replaces the National Pharmaceutical Procurement Unit Act, 2012 to establish the National Medical Supplies Agency as a public service agency responsible for the procurement, warehousing and distribution of drugs and medical supplies in a transparent and cost-effective manner for and on behalf of all public institutions throughout Sierra Leone.